RemeGen

About RemeGen

RemeGen is a biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing first-in-class and best-in-class biologics. It emphasizes therapies for autoimmunity, oncology, and ophthalmology with a global footprint including headquarters in Yantai, China, and R&D centers in China and the United States. The company highlights multiple clinical pipelines and extensive patent activity, underscoring its role as a research-driven developer of innovative biologics for significant diseases.